The Europe ECG electrodes market was valued at USD 238.9 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2030. The increasing burden of cardiovascular disease (CVD) is a major factor contributing to the market growth. According to the European Society of Cardiology, 15% of the total deaths in Europe are due to high blood sugar. CVD is the primary cause of death under the age of 65. Growing product approvals based on innovative technologies and rising demand for disposable electrocardiogram (ECG) electrodes are factors expected to drive market growth in the forecast period.
The worldwide COVID-19 pandemic, which is now an endemic created immense pressure on public health systems and healthcare services globally. This infectious disease had far-reaching effects on the cardiovascular system, resulting in a variety of arrhythmias among those affected. These cardiac issues added a layer of complexity to managing COVID-19, particularly concerning necessary usability. Furthermore, redirecting healthcare resources to combat the pandemic posed challenges for patients accessing crucial emergency services, including reperfusion therapy. The availability of such services was influenced by the local severity of disease, creating additional obstacles for needy individuals.
The rise in cardiovascular disease (CVD) incidence in Europe has generated a substantial demand for medical devices such as electrocardiogram electrodes. With an escalating prevalence of heart-related conditions in the region, healthcare providers and institutions are actively seeking advanced tools to facilitate precise cardiac monitoring, fueling the growth of the ECG electrode industry. As per the European Society of Cardiology, CVD is responsible for 45% of all deaths in the region, and there are more than 11 million new cases reported annually. Moreover, the economic burden of CVD on the region exceeds USD 220 billion each year. This is boosting the market.
The increasing adoption of advanced diagnostic devices drives demand for the Europe electrocardiogram (ECG) electrodes industry. As traditional Holter monitors phase out, the demand for high-quality, compatible ECG electrodes for advanced devices is expected to rise, propelling the demand for disposable electrodes. According to the European Commission’s project CORDIS, the chances of detecting cardiac events via a traditional Holter system are less than 20%, while analyzing the data for 7 days conduits a significant number of resources. Hence, medical product firms are rapidly advancing their research to develop novel products to overcome the deficiencies of traditional ECG devices.
Disposable ECG electrodes offer numerous advantages in electrocardiography, revolutionizing the monitoring of cardiac activities. These electrodes are incredibly convenient. Unlike traditional reusable electrodes that require time-consuming preparation, disposable electrodes are pre-gelled and ready for immediate use. Furthermore, disposable ECG electrodes guarantee accuracy and reliability. Each use provides a fresh, uncontaminated surface for electrode-skin contact, resulting in more precise signal acquisition. This leads to improved diagnostic outcomes, especially in critical situations where accuracy is key. However, the market faces challenges from stringent regulatory guidelines, which impact product development and commercialization.
The Europe ECG electrodes industry is experiencing a wave of innovation, with companies continuously developing new and improved technologies to enhance patient care and outcomes. ECG electrodes are essential tools for recording electrical signals from the heart, providing valuable insights into heart health and function. The growing demand for accurate and reliable ECG monitoring has spurred advancements in electrode materials, design, and manufacturing processes.
Several market players, such as Cardinal Health, General Electric Co, Ambu A/S., and Sorimex, are involved in merger and acquisition activities. Through M&A activity, these companies expand their geographic reach and enter new territories.
Companies are actively investing substantial resources in clinical trials and regulatory submissions to obtain regulatory approval for pipeline products. This results in increasing the cost of developing novel ECG electrodes technologies.
The ECG electrode product line is expanding to meet growing demand. New versions with enhanced features and materials are being introduced to cater to a broader range of user preferences and medical requirements,such as long-term monitoring electrodes for extended use or pediatric electrodes designed for younger patients. The expansion aims to provide more options for healthcare professionals while maintaining high-quality standards.
Disposable segment dominated the market in 2023. The disposable ECG electrodes are designed for single-use end-uses, providing a hygienic and convenient solution for patients and healthcare practitioners. These electrodes are typically made for a specific duration of monitoring, after which they are discarded. The disposable nature minimizes the risk of cross-contamination and infection, making them suitable for short-term monitoring or situations where hygiene is of utmost importance. Additionally, the disposable design eliminates the need for cleaning and sterilization processes, streamlining the workflow for healthcare professionals.
Reusable segment is estimated to register a significant growth over the forecast period. Reusable ECG electrodes are crafted for multiple end-uses, undergoing thorough cleaning and sterilization between uses. These electrodes are durable and cost-effective in the long run, making them suitable for extended monitoring periods or situations where environmental considerations and cost-efficiency are paramount. These aspects are boosting the market.
The monitoring and diagnostic electrodes segment accounted for the largest revenue share of 45.0 % in 2023.Growth in the segment is attributed to the increasing emphasis on preventive healthcare and early diagnosis. Healthcare providers and patients recognize the significance of continuous monitoring and timely diagnostics in managing various medical conditions, increasing the demand for monitoring and diagnostic electrodes in the market. These electrodes, designed to record and transmit vital physiological data, are instrumental in monitoring patients’ heart activity, brain function, muscle responses, and more. Moreover, technological advancements have led to innovative electrode solutions, incorporating materials that enhance comfort, durability, and precision.
Stress test and Holter segment is estimated to register the fastest CAGR over the forecast period. They provide a minimally invasive way to monitor ECG signals, which is a major advantage over traditional monitoring methods, such as invasive catheters. Moreover, technological advancements in electrode materials and designs are leading to the development of more comfortable, durable, and high-quality electrodes. This makes stress test and Holter electrodes even more attractive to healthcare providers and patients. These attributes create favorable demand for stress tests and Holter electrodes for healthcare providers and patients.
Hospital segment dominated the market in 2023. They play a key role in providing comprehensive healthcare services. The high patient volume and diverse medical needs in hospitals make ECG electrodes a fundamental component in cardiac care, aiding healthcare professionals in making informed decisions regarding patient usability and management. As per the European Heart Network, CVD causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU) yearly. In addition, conditions like coronary artery disease, arrhythmias, and heart failure continue to affect a substantial portion of the population. Hence, hospitals are at the forefront of managing these conditions, driving the demand for ECG electrodes to aid in the timely and precise assessment of cardiac health boost the ECG electrodes market.
Ambulatory care centers have been anticipated to grow at the fastest rate during the forecast period. They provide a wide range of healthcare services on an outpatient basis, meaning that patients do not need to stay overnight. The demand for outpatient care is increasing due to factors such as an aging population, the rising prevalence of chronic diseases, and the increasing cost of inpatient care. Moreover, there is a growing emphasis on preventive care, leading to an increased demand for ECG monitoring in ambulatory care centers.
Germany dominated the market in 2023. This dominance is attributed to key industry players, a favorable regulatory environment, substantial investment in research & development (R&D), and a robust reimbursement structure. The increasing incidence of atrial fibrillation (Afib) in Germany further contributes to the country's market growth, presenting lucrative opportunities in the cardiac monitoring sector. According to Deutsches Zentrum für Herz-Kreislaufforschung e.v., around 65,000 people in the country die due to sudden cardiac arrest every year, which also represents 20% of all deaths in the country due to cardiovascular diseases (CVDs). Furthermore, the same source estimates that atrial fibrillation affects nearly 1% of the entire country’s population or nearly 800,000 people. ECG tests are considered the most critical tool for diagnosing cardiac arrhythmias.
UK is expected to grow at the fastest rate during the forecast period. High prevalence of CHD drives growth in UK ECG electrode market. According to an article published by the British Heart Foundation in April 2023, coronary heart disease (CHD) is a major public health concern in the UK and the most common cause of premature deaths, accounting for one in eight deaths among men and one in fourteen deaths among women. The prevalence of CHD continues to rise, and demand for ECG electrodes is also expected to increase.
Cardinal Health, General Electric Co, Ambu A/S., and Sorimex are some of the dominant players operating in Europe ECG electrodes market.
Cardinal Health is a global healthcare services provider. The company operates in over 30 countries and employs about 48,000 people globally.
GE is a global digital industrial company that provides innovative solutions With over 125 years of experience, GE is committed to pushing the boundaries of products to make the world work better.
Ambu A/S. Since its inception in 1937, has been dedicated to reimagining medical solutions to enhance patient care and save lives.
FIAB SpA, Nissha Co. Ltd., and Medico Electrodes International Ltd. are some of the emerging market players functioning in Europe ECG electrode market.
FIAB is an Italian medical device company with over 40 years of experience manufacturing and distributing products and solutions for various medical specialties.
Nissha Group aims to enrich people's lives by using diverse capabilities and leadership to create valuable product.
In January 2022, Philips introduced a new at-home, 12-lead ECG solution for decentralized clinical trials. This solution is designed to improve compliance, patient recruitment and retention by reducing the need for site visits.
In June 2022, AliveCor released the KardiaMobile Card, a credit-card-sized ECG device that provides a medical-grade ECG in 30 seconds. It is the world's first FDA-cleared credit-card-sized ECG device.
In March 2021, Rhythmlink received FDA clearance for its new Sticky Pad Surface Electrodes, used for Intraoperative Neurophysiological Monitoring (IONM) and Electroencephalography (EEG) in 1.5 and 3 Tesla MRI environments.
In September 2021, Bittium's launched new OmegaSnap patch electrodes offer 1-CH, 2-CH, and 3-CH ECG measurements compatible with the Bittium Faros ECG device.
Market size value in 2024
USD 248.6 million
Revenue forecast in 2030
USD 322.4 million
CAGR of 4.4% from 2024 to 2030
Base year for estimation
2018 - 2022
2024 - 2030
Revenue in USD million and CAGR from 2024 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Product, usability, end-use, region
U.K.; Germany; France; Spain; Italy; Poland; Netherlands; Turkey; Serbia; Bosnia and Herzegovina; Czech Republic; Slovakia; Ukraine; Ireland; Greece; Portugal; Denmark; Sweden; Norway; Finland; Lithuania; Latvia; Estonia; Romania; Austria; Belgium; Bulgaria; Croatia; Switzerland; Hungary.
Key companies profiled
Cardinal Health; General Electric Co; VectraCor Inc.; ADInstruments Pty Ltd.; Sorimex; Medico Electrodes; International Ltd.; Ambu A/S.; Nikomed USA Inc.; Leonhard Lang USA, Inc.; Nissha Co. Ltd.; Bio-Protech Inc.; Taylor Industries; 3M; FIAB SpA; BSS MEDICAL, SUPPLY CO. LIMITED; Esvico Sp. z o.o.; FARUM sp. z o.o.; CONMED Corporation.
Free report customization (equivalent up to 8 analyst's working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options.
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global Europe ECG electrodes market report based on product, usability, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Stress Test & Holter Electrodes
Monitoring & Diagnostic Electrodes
Pediatric & Neonatal Electrodes
Usability Outlook (Revenue, USD Million, 2018 - 2030)
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Ambulatory Care Centers
Regional Outlook (Revenue, USD Million 2018 - 2030)
Bosnia and Herzegovina
b. The Europe ECG Electrodes market is expected to grow at a compound annual growth rate of 4.4% from 2024 to 2030 to reach USD 322.4 by 2030.
b. Germany accounted for the largest share in 2022. The growing number of interventional electrophysiology procedures in the country is expected to drive the market for ECG electrodes during the forecast period.
b. Some of the prominent players in the ECG Electrodes market are Cardinal, Medico, GE Healthcare, Conmed, Sorimex, Ambu, 3M, and others
b. The Europe ECG Electrodes market size was estimated at USD 238.9 million in 2023 and is expected to reach USD 248.6 million in 2024.
b. The growing burden of cardiovascular disease (CVD) in Europe created a high demand for medical devices like ECG electrodes. As the region faces an increasing prevalence of heart-related conditions, healthcare providers and institutions are seeking advanced tools to facilitate accurate cardiac monitoring, driving the expansion of the ECG electrode industry.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."